Protection Extended for State Medical Marijuana Programs

US Congress Protects State Marijuana

After a brief government shutdown, protection for state medical marijuana programs was extended again until March 23, 2018.  Congress and the President signed off on a six-week continuing resolution.

The budget resolution extends the Rohrabacher-Blumenauer Amendment which prohibits the use of funds to prevent certain States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana.  That language was initially passed by Congress in 2014 as the Rohrabacher-Farr Amendment (H.Amdt.748) and is now known as the Rohrabacher-Blumenauer Amendment.  This is the eighth time the amendment has been temporarily extended by a continuing resolution from Congress, which hasn’t passed a new federal budget since 2015.

The Rohrabacher-Blumenauer Amendment was supported by a bipartisan group letter to House and Senate leadership from 66 Congress members including Rep. Dana Rohrabacher, R-California, and Rep. Earl Blumenauer, D-Oregon.

Also in support of the Rohrabacher-Blumenauer Amendment was a letter from California State Treasurer John Chiang.  Read more about state cannabis law at California Cannabis Law.

Contact us to learn more about California state or local cannabis regulations, cannabis regulatory compliance, and cannabis litigation.

Legalization of Cannabis in Colorado Associated with Reductions in Opioid Deaths

Marijuana and Opioids

Researchers from the University of North Texas School of Public Health, the University of Florida, and Emory University published a study which found that legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths.  The study was published in the American Journal of Public Health.

The researchers set out to examine the association between Colorado’s legalization of recreational cannabis use and opioid-related deaths.  They compared changes in opioid-related deaths before and after Colorado stores began selling recreational cannabis.

The study results showed that Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths.  This reduction represented a reversal of the upward trend in opioid-related deaths in Colorado.

See the study – Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado.

Contact us to learn more about California state or local cannabis regulations, cannabis regulatory compliance, and cannabis litigation.